NCT04180176CompletedPhase 4
Prospective Clinicogenomic Program
A Multicenter, Low-Interventional Study to Evaluate the Feasibility of a Prospective Clinicogenomic Program
Source: ClinicalTrials.gov · Last updated 17 Jan 2024
Brief summary (registry, in English)
The main purpose of this study is to evaluate the feasibility of a scalable, prospective research program for participants with metastatic non-small cell lung cancer (mNSCLC) or extensive-stage small-cell lung cancer (ES-SCLC) planning to start standard-of-care (SOC) systemic anti-cancer treatment. The study will also examine ctDNA status over the course of treatment as a predictor of response to therapy.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 945 (actual)
- First submitted
- 19 Nov 2019
- Start date
- 13 Dec 2019
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- Genentech, Inc.
- Diseases
- Lung cancer
- NCT number
- NCT04180176
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 945
- From 13 Dec 2019 to the primary completion date, 30 Nov 2023
- 23 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- \- Participant actively receiving investigational medicinal product(s) as part of an interventional trial at the time of signing informed consent
Who the study is looking for
- Documented diagnosis of mNSCLC or ES-SCLC
- Planned initiation of SOC systemic anti-cancer treatment
- Front-Line Immunotherapy Cohort: Received front-line treatment of an immune blockade therapy including anti-CTLA-4, anti-PD-1, or anti-PD-L1 therapeutic antibody on Protocol GX41563
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (23)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Cancer & Blood Center, LLC; Research Coordinator of this site? Confirm its status | Athens | United States | Unknown status |
| Piedmont Cancer Institute, PC Coordinator of this site? Confirm its status | Atlanta | United States | Unknown status |
| Alabama Oncology Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
| Ironwood Cancer & Research Centers Coordinator of this site? Confirm its status | Chandler | United States | Unknown status |
| SCRI Tennessee Oncology Chattanooga Coordinator of this site? Confirm its status | Chattanooga | United States | Unknown status |
| Regional Cancer Care Associates LLC, Central Jersey Division Coordinator of this site? Confirm its status | East Brunswick | United States | Unknown status |
| Hematology Oncology Associates of Central New York Coordinator of this site? Confirm its status | East Syracuse | United States | Unknown status |
| Florida Cancer Specialists; Department of Oncology Coordinator of this site? Confirm its status | Fort Myers | United States | Unknown status |
| Fort Wayne Med Oncology & Hematology Inc Coordinator of this site? Confirm its status | Fort Wayne | United States | Unknown status |
| Hematology Oncology Associates of Fredericksburg Inc Coordinator of this site? Confirm its status | Fredericksburg | United States | Unknown status |
| Cancer & Hematology Centers of Western Michigan Coordinator of this site? Confirm its status | Grand Rapids | United States | Unknown status |
| Clearview Cancer Institute Coordinator of this site? Confirm its status | Huntsville | United States | Unknown status |
| Jackson Oncology Associates PLLC Coordinator of this site? Confirm its status | Jackson | United States | Unknown status |
| Southeast Nebraska Cancer Ctr Coordinator of this site? Confirm its status | Lincoln | United States | Unknown status |
| Tennessee Oncology Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
| Yale University Coordinator of this site? Confirm its status | New Haven | United States | Unknown status |
| West Clinic Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| National Translational Research Group Coordinator of this site? Confirm its status | Port Jefferson Station | United States | Unknown status |
| Virginia Cancer Institute - Richmond Coordinator of this site? Confirm its status | Richmond | United States | Unknown status |
| Florida Cancer Specialist, North Region Coordinator of this site? Confirm its status | St. Petersburg | United States | Unknown status |
| SCRI Florida Cancer Specialists PAN Coordinator of this site? Confirm its status | Tallahassee | United States | Unknown status |
| Oklahoma Cancer Specialists and Research Institute Coordinator of this site? Confirm its status | Tulsa | United States | Unknown status |
| Florida Cancer Specialists Coordinator of this site? Confirm its status | West Palm Beach | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.